252 related articles for article (PubMed ID: 1778754)
1. P450 and human cancer.
Kawajiri K; Fujii-Kuriyama Y
Jpn J Cancer Res; 1991 Dec; 82(12):1325-35. PubMed ID: 1778754
[TBL] [Abstract][Full Text] [Related]
2. Specificity of cDNA-expressed human and rodent cytochrome P450s in the oxidative metabolism of the potent carcinogen 7,12-dimethylbenz[a]anthracene.
Shou M; Korzekwa KR; Krausz KW; Buters JT; Grogan J; Goldfarb I; Hardwick JP; Gonzalez FJ; Gelboin HV
Mol Carcinog; 1996 Dec; 17(4):241-9. PubMed ID: 8989918
[TBL] [Abstract][Full Text] [Related]
3. Metabolism of 5-methylchrysene and 6-methylchrysene by human hepatic and pulmonary cytochrome P450 enzymes.
Koehl W; Amin S; Staretz ME; Ueng YF; Yamazaki H; Tateishi T; Guengerich FP; Hecht SS
Cancer Res; 1996 Jan; 56(2):316-24. PubMed ID: 8542586
[TBL] [Abstract][Full Text] [Related]
4. Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1.
Shimada T; Hayes CL; Yamazaki H; Amin S; Hecht SS; Guengerich FP; Sutter TR
Cancer Res; 1996 Jul; 56(13):2979-84. PubMed ID: 8674051
[TBL] [Abstract][Full Text] [Related]
5. Metabolic activation of heterocyclic amines and other procarcinogens in Salmonella typhimurium umu tester strains expressing human cytochrome P4501A1, 1A2, 1B1, 2C9, 2D6, 2E1, and 3A4 and human NADPH-P450 reductase and bacterial O-acetyltransferase.
Oda Y; Aryal P; Terashita T; Gillam EM; Guengerich FP; Shimada T
Mutat Res; 2001 May; 492(1-2):81-90. PubMed ID: 11377247
[TBL] [Abstract][Full Text] [Related]
6. Individuality in cytochrome P450 expression and its association with the nephrotoxic and carcinogenic effects of chemicals.
Wolf CR
IARC Sci Publ; 1991; (115):281-7. PubMed ID: 1820342
[TBL] [Abstract][Full Text] [Related]
7. Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.
Shimada T; Yamazaki H; Mimura M; Inui Y; Guengerich FP
J Pharmacol Exp Ther; 1994 Jul; 270(1):414-23. PubMed ID: 8035341
[TBL] [Abstract][Full Text] [Related]
8. Kinetic analysis of the activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by heterologously expressed human P450 enzymes and the effect of P450-specific chemical inhibitors on this activation in human liver microsomes.
Patten CJ; Smith TJ; Murphy SE; Wang MH; Lee J; Tynes RE; Koch P; Yang CS
Arch Biochem Biophys; 1996 Sep; 333(1):127-38. PubMed ID: 8806763
[TBL] [Abstract][Full Text] [Related]
9. Metabolic activation of the potent carcinogen dibenzo[a,h]anthracene by cDNA-expressed human cytochromes P450.
Shou M; Krausz KW; Gonzalez FJ; Gelboin HV
Arch Biochem Biophys; 1996 Apr; 328(1):201-7. PubMed ID: 8638931
[TBL] [Abstract][Full Text] [Related]
10. Metabolic genetic polymorphisms and susceptibility to lung cancer.
Bouchardy C; Benhamou S; Jourenkova N; Dayer P; Hirvonen A
Lung Cancer; 2001 May; 32(2):109-12. PubMed ID: 11325480
[TBL] [Abstract][Full Text] [Related]
11. Procarcinogen activation by cytochrome P450 3A4 and 3A5 expressed in Escherichia coli and by human liver microsomes.
Yamazaki H; Inui Y; Wrighton SA; Guengerich FP; Shimada T
Carcinogenesis; 1995 Sep; 16(9):2167-70. PubMed ID: 7554070
[TBL] [Abstract][Full Text] [Related]
12. Activation of procarcinogens by human cytochrome P450 enzymes expressed in Escherichia coli. Simplified bacterial systems for genotoxicity assays.
Shimada T; Gillam EM; Sandhu P; Guo Z; Tukey RH; Guengerich FP
Carcinogenesis; 1994 Nov; 15(11):2523-9. PubMed ID: 7955101
[TBL] [Abstract][Full Text] [Related]
13. Oltipraz-mediated changes in aflatoxin B(1) biotransformation in rat liver: implications for human chemointervention.
Buetler TM; Bammler TK; Hayes JD; Eaton DL
Cancer Res; 1996 May; 56(10):2306-13. PubMed ID: 8625305
[TBL] [Abstract][Full Text] [Related]
14. Selectivity of polycyclic inhibitors for human cytochrome P450s 1A1, 1A2, and 1B1.
Shimada T; Yamazaki H; Foroozesh M; Hopkins NE; Alworth WL; Guengerich FP
Chem Res Toxicol; 1998 Sep; 11(9):1048-56. PubMed ID: 9760279
[TBL] [Abstract][Full Text] [Related]
15. Modulation of the cytochrome P450 system as a mechanism of chemoprotection.
Wolf CR; Mahmood A; Henderson CJ; McLeod R; Manson MM; Neal GE; Hayes JD
IARC Sci Publ; 1996; (139):165-73. PubMed ID: 8923029
[TBL] [Abstract][Full Text] [Related]
16. Metabolism of ochratoxin A: absence of formation of genotoxic derivatives by human and rat enzymes.
Gautier J; Richoz J; Welti DH; Markovic J; Gremaud E; Guengerich FP; Turesky RJ
Chem Res Toxicol; 2001 Jan; 14(1):34-45. PubMed ID: 11170506
[TBL] [Abstract][Full Text] [Related]
17. A quantitative comparison of dibenzo[a,l]pyrene-DNA adduct formation by recombinant human cytochrome P450 microsomes.
King LC; Adams L; Allison J; Kohan MJ; Nelson G; Desai D; Amin S; Ross JA
Mol Carcinog; 1999 Oct; 26(2):74-82. PubMed ID: 10506751
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory monoclonal antibodies to human cytochrome P450 1A2: analysis of phenacetin O-deethylation in human liver.
Yang TJ; Sai Y; Krausz KW; Gonzalez FJ; Gelboin HV
Pharmacogenetics; 1998 Oct; 8(5):375-82. PubMed ID: 9825829
[TBL] [Abstract][Full Text] [Related]
19. Human enzymes involved in the metabolic activation of the environmental contaminant 3-nitrobenzanthrone: evidence for reductive activation by human NADPH:cytochrome p450 reductase.
Arlt VM; Stiborova M; Hewer A; Schmeiser HH; Phillips DH
Cancer Res; 2003 Jun; 63(11):2752-61. PubMed ID: 12782579
[TBL] [Abstract][Full Text] [Related]
20. Activation of procarcinogens by human cytochrome P450 enzymes.
Guengerich FP; Shimada T
Mutat Res; 1998 May; 400(1-2):201-13. PubMed ID: 9685642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
